Increased HOX C13 expression in metastatic melanoma progression
Monica Cantile(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Gerardo Botti(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 43
Related Papers
Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients
|International Journal of Molecular Sciences|2017|112
Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma
|Journal of Cancer|2017|51